Treatment of Patients With RAD001 With Progressive Sarcoma
Status:
Completed
Trial end date:
2017-05-17
Target enrollment:
Participant gender:
Summary
The purpose of this multicenter, three-arm, exact binomial single-stage, phase II trial is to
determine the preliminary efficacy and safety of RAD001 in patients with histological
evidence of progressive or metastatic bone or soft tissue sarcoma.